©Treatment Research Institute, 2012 9/20/2015 Why Integrate Addiction Care into Mainstream Medicine? ©Treatment Research Institute, 2013 A. Thomas McLellan.

Slides:



Advertisements
Similar presentations
Addressing Addiction and Substance Use in National Health Reform Eric Goplerud, Ph.D. Alliance for Health Care Reform July 17, 2009 Center for Integrated.
Advertisements

TRI science addiction Lost Opportunity? SBI for Substance Abuse In ERs and Trauma Centers Academy Health Mady Chalk, Ph.D. Treatment Research Institute.
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Parity 101: What does it Mean for Behavioral Health Services? Sandra Naylor Goodwin, PhD, MSW California Institute for Mental Health June 2, 2011.
SBIRT Screening, Brief Intervention and Referral to Treatment.
Christine Pace, MD, MSc Assistant Professor of Medicine, Boston University School of Medicine Lee Ellenberg, LICSW Training Manager, MASBIRT Training and.
Maria A. Wamsley, MD Professor of Clinical Medicine UCSF School of Medicine.
Incorporating Behavioral Health in the EHR to Improve Care Insitute of Medicine | November 25, 2013 Brigid McCaw, MD, MS, MPH, FACP Medical Director, Family.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
A Report From The Field Student-Run Free Clinics: An Equitable Local Solution to National Healthcare Disparities Kavelin Rumalla 1, Adithi Reddy 1, Antonio.
1 1 DSHS | Planning, Performance and Accountability ● Research and Data Analysis Division ● FEBRUARY 2011 Substance Abuse Treatment Opportunities for Health.
Medical Director Jackson County Health and Human Services
SBIRT Introduction and Relevance to DGIM Jason Satterfield, PhD SBIRT Collaborative Education Project Funded by SAMHSA/CSAT Grant 1U79TI
Chronic Pain Initiative CCNC and Project Lazarus: Chronic Pain and Community Initiative.
Connecting LEGACY PRIMARY CARE and depaul treatment centers
Substance Use Disorders, Primary Care, Screening and Brief Intervention Norman Wetterau, MD, FASAM President: New York Society of Addiction Medicine.
Mental Illness and Addiction: Changing Perspectives Presented by Terri White, MSW Commissioner Oklahoma Department of Mental Health and Substance Abuse.
Addiction Treatment Works! Through Collaboration and Problem Solving amongst all disciplines.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
What Will it Take to Get Medicine to Screen and Intervene with Alcohol and Other Drugs? Two Stories about Research, Politics, Finance, Value and Business.
Healthcare Reform The “Affordable Care Act” How Will It Affect Substance Abuse Care?
The National Prevention Strategy and Behavioral Health Care: Prevention Is Now RADM Peter J. Delany, Ph.D., LCSW-C Substance Abuse and Mental Health Services.
Rx for Success Next Steps to Prevent Prescription Drug Abuse Rebecca Hebner, MPH Substance Abuse Prevention Systems Coordinator.
©Treatment Research Institute, /5/2015 Why Integrate Addiction Care into Mainstream Medicine? ©Treatment Research Institute, 2013 A. Thomas McLellan.
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
What are we doing in Southern Oregon? Concerns about opioid prescribing practices.
Opioid Use in Work-related Injuries Pacific Northwest Chapter - Association of Occupational Health Professionals (AOHP) January 4, 2011 Jaymie Mai, PharmD.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Addressing Substance Use Disorders Translating Science To Policy In The 2010 Drug Control Strategy.
Integration in Behavioral Health: Making the Most of New Opportunities Richard G. Frank Assistant Secretary for Planning and Evaluation.
Alcohol-Related Emergency Department Visits in the United States Center to Prevent Alcohol Problems Boston University School of Public Health Ralph Hingson,
Origin and Process of Utah Guidelines Anna Fondario, MPH Utah Department of Health Violence and Injury Prevention Program.
Click to edit Master subtitle style Aetna Behavioral Health Depression Initiatives June 2006.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Alcohol Screening and Brief Interventions for Patients with Non-communicable Diseases Thomas F. Babor Department of Community Medicine University of Connecticut.
Statewide Quality Advisory Committee Quality Priorities September 21, 2015 Beth Waldman and Michael Joseph.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
InSight into Screening, Brief Intervention, Referral, and Treatment.
The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny,
Pain Management: Narcotics, Implantable Therapies Maher Fattouh MD Adjunct Assistant Clinical Professor University Wisconsin Medical Director, Advanced.
Moving the focus upstream: Teaching about (and caring for) patients with complex illness in the Family Medicine Center and across the continuum Allen Perkins,
Behavioral Health: Access Issues Allen J. Brenzel, M.D., MBA Medical Director, BHDID Cabinet for Health and Family Services.
Use of Mentored Residency Teams to Enhance Addiction Medicine Education Maureen Strohm, MD, Ken Saffier, MD, Julie Nyquist, PhD, Steve Eickelberg, MD MERF.
2 PBM+ An Integrated Model for Behavioral Health Care Kiran Taylor, MD Chief, Division of Psychiatry and Behavioral Medicine Spectrum Health Medical Group.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
RTI International is a trade name of Research Triangle Institute The Costs of SBI: Findings from the literature Presented by Jeremy Bray, Gary.
©Treatment Research Institute, /16/2016 Prevention: Moving from Science to Practice ©Treatment Research Institute, 2013 A. Thomas McLellan Treatment.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Wireless Access SSID: cwag2017
Treatment Access A Substance Use Disorder Perspective
screening, brief intervention and referral to treatment
Illinois’ 1115 Behavioral Health Transformation Waiver
National Health Reform is Essential
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
Screening, Brief Intervention and Referral to Treatment
Value of Pharmaceuticals in Managed Care Pharmacy
What is InSight? $17 million five-year SAMHSA grant
ROOM project Addressing the Opioid Epidemic in the U.P.
Opioid Prescribing & Monitoring
Value of Pharmaceuticals in Managed Care Pharmacy
Part I Why Integrate Addiction Care into Mainstream Medicine?
Addiction Why It’s YOUR Business
Opioids in Butte County
Developing and Using a Referral Network
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Rationale –Evidence Base
Massachusetts Consultation Service for the Treatment of Addiction and Pain (MCSTAP) Offers real-time phone consultation to primary care practices on safe.
Transforming the Delivery of Substance Use Disorder Treatment in States Update August 2019.
Presentation transcript:

©Treatment Research Institute, /20/2015 Why Integrate Addiction Care into Mainstream Medicine? ©Treatment Research Institute, 2013 A. Thomas McLellan Treatment Research Institute Part I

Closing Thoughts Substance use disorders” will soon be a regular part of mainstream healthcare: 1.SUDs are too omnipresent, dangerous & expensive in healthcare to be ignored 2.Market forces will accelerate integration o Insurance benefits will bring new meds, continuing care protocols & other tools 3.Mainstream healthcare can do this! o Several protocols already fit into the system

Substance Use Among US Adults Addiction ~ 23,000,000 “Harmful – 40,000,000 Use” Little or No Use Little/No Use Very Serious Use In Treatment ~ 2,300,000

1 1.Because it will improve general medical care 2. Because it will save money 3.Because it’s the law.

1 1.Because it will improve general medical care 2. Because it will save money 3.Because it’s the law.

Alcohol and drug use - even at levels below “addiction” - regularly lead to: misdiagnoses, poor adherence to prescribed care, interference with commonly prescribed medications, greater amounts of physician time, unnecessary medical testing, poor outcomes and increased costs particularly in the management of chronic illness. Substance Use Impact on Healthcare Vinson D, Ann Fam Med, Brown RL, J Amer Board Fam Prac, Humeniuk R, WHO, Manwell LB, J Addict Dis, Longabaugh R. Alcohol Res Health, Healthiest Wisconsin 2010, WI DHFS, USPSTF, Screening for Alcohol Misuse, National Quality Forum, National Voluntary Consensus Standards, Bernstein J, Drug Alcohol Depend, Saunders B, Addiction, Stephens RS, J Consult Clin Psychol, Copeland J, J Subst Abuse Treat Fleming MF, Med Care, Fleming MF, Alcohol Clin Exp Res, Gentilello LM, Ann Surg, Estee S, Medicaid Cost Outcomes, Interim Report , Washington State Department of Social and Health Services. Yarnall KSH, Am J Public Health, Solberg LI, Am J Prev Med, National Committee on Prevention Priorities, 6

Systematic Reviews Diabetes: –Howard et al. Ann Intern Med. Hypertension: –McFadden et al. Am J Hypertens. Chronic pain: –Martell et al. Ann Intern Med. Breast cancer: –Terry et al. Ann Epidemiol. Sleep: –Dinges et al. JAMA

Risk of Mortality & Drinks/Day Drinks per Day Risk of Mortality 34 Di Castelnuovo et al. Arch. Int. Med. 2006;166(22):2437

Low-Risk Drinking Limits Source: NIAAA, Rethinking Drinking: Alcohol and Your Health, 2009

1

Alcohol Use and Breast Cancer Before Diagnosis – heavy drinkers 1.5 times chance of contracting 2.3 times chance w/BRAC2 gene After Diagnosis – ANY Drinking Increases risk of relapse Interferes radio & chemo therapy

1

Phillips, D. P. et al. 2008;168: Alc/Drg Related Fatal Errors FME Death Rate P otential impact on Safety : Fatal Medical Errors

BU study of 87 patients with undisclosed opioid use receiving primary care at BU Medical Center. 100% received at least one medication with a significant drug-drug interaction Average number of significant interactions = 5 15 of 87 patients ( 17% ) were treated by ED for their interaction ( $$$ ) Drug-Drug Interactions – Safety Issues Walley et al., J. Gen Internal Medicine, 24(9): , 2009

1

Causes of Accidental Death #1 Opioid Overdose #2 Car Accidents #3 Accidental Shooting Source: CDC, 2013

Two Studies of Opioid Overdose Hall et. Al. JAMA, 2008 Dunn et al. Annals Int. Med, 2009

Study 2 – Dunn et al, Annals 2009 Prescription Drug Overdose Within a Managed Care Environment –Group Health study of overdose incidents and deaths – 3,000 overdose reports in 2008 –Examined case histories and prescription records Death Rate of 11 / 100,000 –Predictors = Male; 30-50; Low SES; MH/SA; OD history; Bz script; <10 days after script. 27% of reports had prior OD incident

Pain Society and State Guidelines for Pain Management Model policy for the use of opioids in the treatment of pain. s.pdf Gilson AM, Joranson DE, Maurer MA. Improving state pain policies: recent progress and continuing opportunities. CA Cancer J Clin. 2007;57(6):341–353

1.Screening for & discussing substance use 2.Patient contract – Single doc & pharmacy 3.Patient & family education on safe storage of medications 4.Urine Screening pre and during prescribing (expanded test panel)

1 1.Because it will improve general medical care 2. Because it will save money 3.Because it’s the law.

Why are SA Benefits “Essential” Addiction ~ 23,000,000 “Harmful – 40,000,000 Use” Little or No Use Little/No Use Very Serious Use In Treatment ~ 2,300,000 $120B/yr

1

Population Prevalence Addiction ~ 25,000,000 “Harmful – 60,000,000 Use” Little or No Use LITTLE LOTS In Treatment ~ 2,300,000 Target Group Population Prevalence 24 X

25 Major Advances in Brief Interventions “Harmful substance use” is accurately identified with 2 – 3 questions. –Prevalence rates of 20 – 50% in healthcare –60% of all ER admissions (10 million/yr) Brief counseling (5 – 10 minutes) by produces lasting changes & savings

Washington’s Screening Brief Intervention & Treatment Evaluation SBIRT in 9 Emergency Depts. Case Control Study of 1557 pts – Matched group – got ER care but no BI Measured healthcare utilization and costs for one year

Medicaid Costs Following SBIRT in Washington State SBIRT patients = 1557 Matched controls = 1557 Medicaid Costs PM/PM Estee et al. Medical Care $4,000 Savings PM/PY

1 1.Because it will improve general medical care 2. Because it will save money 3.Because it’s the law.

2009 Parity Act “MHPAEA” “ If ” a health plan covers MH/SA benefits should be comparable to those of similar physical illnesses”

2010 Affordable Care Act SA care is “Essential Service” SA is firmly part of healthcare Funds full continuum of care Prevent, BI, Meds, Spec Care Significant change in benefit The nature/number of benefits The types of eligible providers

SUD Benefits Today Addiction ~ 23,000,000 “Harmful – 40,000,000 Use” Little or No Use Little/No Use Very Serious Use In Treatment ~ 2,300,000 Addiction

SUD Benefits Under ACA Addiction ~ 23,000,000 “Harmful – 40,000,000 Use” Little or No Use Little/No Use Very Serious Use In Treatment ~ 2,300,000 Benefit for “Substance Use Disorders”

Closing Thoughts “Substance use disorders” will be part of mainstream healthcare: 1.SUDs are too omnipresent, expensive & dangerous in healthcare to be ignored 2.Market forces will accelerate integration o Insurance benefits will bring new meds, continuing care protocols & other tools 3.Mainstream healthcare can do this! o Several protocols already fit into the system